A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer

NCT06464601 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

COMBINATION_PRODUCT: fruquintinib combined with immune checkpoint inhibitors and chemotherapy
COMBINATION_PRODUCT: fruquintinib combined with immune checkpoint inhibitors and chemotherapy

Sponsor

Wuhan University